Members Capital Advisors Inc’s Bristol-Myers Squibb BMY Stock Holding History

Members Capital Advisors Inc’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-22,102	Closed	-$1.28M	–	31
2023 Q3	$1.28M	Sell	22,102 -9,606	-30%	-$589K	1.59%	23
2023 Q2	$2.03M	Hold	31,708	–	–	2.08%	10
2023 Q1	$2.2M	Hold	31,708	–	–	1.59%	19
2022 Q4	$2.28M	Hold	31,708	–	–	1.64%	17
2022 Q3	$2.25M	Hold	31,708	–	–	1.78%	13
2022 Q2	$2.44M	Hold	31,708	–	–	1.77%	15
2022 Q1	$2.32M	Buy	31,708 +4,708	+17%	+$316K	1.49%	25
2021 Q4	$1.68M	Hold	27,000	–	–	0.86%	46
2021 Q3	$1.6M	Hold	27,000	–	–	0.87%	41
2021 Q2	$1.8M	Hold	27,000	–	–	1.12%	22
2021 Q1	$1.71M	Hold	27,000	–	–	1.31%	24
2020 Q4	$1.68M	Hold	27,000	–	–	1.42%	26
2020 Q3	$1.63M	Buy	+27,000	New	+$1.63M	1.53%	28

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Members Capital Advisors Inc's BMY Position: Q4 2023 in Review

Members Capital Advisors Inc sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 22,102 shares — an estimated $1.28M sold.

Members Capital Advisors Inc first reported a position in BMY in Q3 2020 and held it in 13 quarters. The position peaked at $2.44M in Q2 2022. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Members Capital Advisors Inc reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Members Capital Advisors Inc sold 22,102 Bristol-Myers Squibb shares in Q4 2023, an estimated $1.28M.
Members Capital Advisors Inc first reported a position in Bristol-Myers Squibb in Q3 2020 and held it in 13 quarters.
Members Capital Advisors Inc's Bristol-Myers Squibb position peaked at $2.44M in Q2 2022.
2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Members Capital Advisors Inc's 13F filing for Q4 2023, filed 2 Feb 2024.